-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
- Amylyx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$489K, a 90.4% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $11.9M.
- Amylyx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$180M, a 140% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)